Alnylam Pharmaceuticals (ALNY) PT Raised to $206 at Leerink Partners
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Price: $227.12 +1.42%
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Leerink Partners analyst Mani Foroohar raised the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $206.00 (from $200.00) while maintaining a Market Perform rating.
You May Also Be Interested In
- Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
- Hon Hai Precision Industry Co Ltd. (2317:TT) (HNHPD) PT Raised to NT$435 at Macquarie
- Square Enix Holdings (9684:JP) (SQNNY) PT Raised to JPY3,100 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
